Targeted internal radiation treatment for selected liver tumors.
Request Medical OpinionAdvanced treatment information for international patients and healthcare professionals.
Yttrium-90 radioembolization is delivered through liver arteries for selected liver tumors.
It may be evaluated for selected primary liver tumors and liver metastases.
Patients usually undergo angiographic mapping and nuclear medicine assessment before final treatment.
Interventional radiology, nuclear medicine, oncology and hepatobiliary teams may be involved.
Eligibility depends on tumor type, liver function, vascular anatomy and performance status.
It delivers radiation directly to selected liver tumor areas.
Liver MRI/CT, PET/CT, pathology and liver function tests may be needed.
Feasibility and cost depend on mapping results and medical evaluation.
Patients should submit medical reports, imaging files, pathology results, previous treatment history and current clinical information.
Our team organizes the case and coordinates specialist evaluation before treatment planning, estimated duration and quotation.
Submit Your ReportsTreatment suitability, protocol, number of sessions, hospital stay and cost depend on diagnosis, disease stage, previous treatments and specialist evaluation.
Send your reports and receive professional treatment planning support.